Developer docs
API playgroundTry for free, no card

Search company profiles

Galatea Surgical

Full company profile

uuid0008n4s

Namestring
Galatea Surgical
Company typeenum
Private
Founded yearint
2011
Short descriptiontext

Galatea Surgical is a Lexington, MA-based medical device firm founded in 2011 that develops the GalaFLEX Scaffold for soft tissue repair and reinforcement in aesthetic plastic and reconstructive surgery, commercially aligned with Becton Dickinson.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLexington, United States
HQ citystring
Lexington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
surgical scaffold devices, soft tissue reinforcement, plastic surgery implants, reconstructive surgery products, bioresorbable scaffolds
Industry1 code
1Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets)
CodeHLAHADALPrimaryYes
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Plastic and Reconstructive Surgery Medical Devices
Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Regulatory
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Galatea Surgical is a medical device company that develops and markets the GalaFLEX Scaffold, a surgical scaffold device designed for soft tissue repair and reinforcement during aesthetic plastic and reconstructive surgery procedures. The company sells its products to surgical and medical professionals requiring tissue support scaffolds.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1GalaFLEX Scaffold
No data
Peers6 records
TypeBroad incumbent
TypeBroad incumbent
Description

Medtronic's Surgical Innovations business (which absorbed Covidien) markets a wide range of hernia meshes, soft-tissue fixation devices, and reinforcement products overlapping with Galatea's scaffold category across reconstructive and general surgery.

TypeDirect peer
Description

Integra LifeSciences develops regenerative tissue technologies and surgical scaffolds used in reconstructive, neurosurgical, and plastic surgery — a directly comparable product category to Galatea's soft-tissue reinforcement scaffolds.

TypeBroad incumbent
Description

Ethicon is J&J's surgical wound closure and mesh division, offering a broad portfolio of soft-tissue reinforcement meshes, sutures, and adjunctive products used in the same aesthetic and reconstructive surgery indications where Galatea Surgical's GalaFLEX Scaffold competes.

TypeBroad incumbent
Description

Allergan Aesthetics supplies products into the plastic and reconstructive surgery channel that Galatea targets, including tissue-support and breast-reconstruction adjuncts, and represents a competing commercial footprint in aesthetic surgery.

TypeBroad incumbent
Description

BD appears to be the commercial partner branding GalaFLEX. As a global medical device conglomerate with its own surgical mesh, suture, and biosurgery lines, BD is both a likely owner/partner and a direct competitive incumbent in soft-tissue reinforcement.

Market position
Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Galatea Surgical

Plastic and Reconstructive Surgery Medical Devicesgalateasurgical.com

Galatea Surgical is a Lexington, MA-based medical device firm founded in 2011 that develops the GalaFLEX Scaffold for soft tissue repair and reinforcement in aesthetic plastic and reconstructive surgery, commercially aligned with Becton Dickinson.

Galatea Surgical firmographics

Firmographics
Name
Galatea Surgical
Website
https://galateasurgical.com
Company type
Private
Founded year
2011
Headcount range
11–50 employees
Short description
Galatea Surgical is a Lexington, MA-based medical device firm founded in 2011 that develops the GalaFLEX Scaffold for soft tissue repair and reinforcement in aesthetic plastic and reconstructive surgery, commercially aligned with Becton Dickinson.
Ownership category
akta.pro rank

Galatea Surgical industry classification

Industry
Product category
Plastic and Reconstructive Surgery Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

Keywords

  • Surgical scaffold devices
  • Soft tissue reinforcement
  • Plastic surgery implants
  • Reconstructive surgery products
  • Bioresorbable scaffolds

Where Galatea Surgical is headquartered

Location

Headquarters

HQ city
Lexington
HQ country
United States
HQ region
North America

Markets served

Galatea Surgical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Regulatory

Galatea Surgical product offering

Product offering

Core offering

Galatea Surgical is a medical device company that develops and markets the GalaFLEX Scaffold, a surgical scaffold device designed for soft tissue repair and reinforcement during aesthetic plastic and reconstructive surgery procedures. The company sells its products to surgical and medical professionals requiring tissue support scaffolds.

Differentiator

Problem solved

Functional benefit

Products and services

  • GalaFLEX Scaffold

Companies that use Galatea Surgical

Customer profile

Segments1 record

Ideal customer profiles1 record

Galatea Surgical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Galatea Surgical competitors and assessment

Company assessment

Broad incumbents

  • Coloplast:
  • Medtronic: Medtronic's Surgical Innovations business (which absorbed Covidien) markets a wide range of hernia meshes, soft-tissue fixation devices, and reinforcement products overlapping with Galatea's scaffold category across reconstructive and general surgery.
  • Ethicon (Johnson & Johnson): Ethicon is J&J's surgical wound closure and mesh division, offering a broad portfolio of soft-tissue reinforcement meshes, sutures, and adjunctive products used in the same aesthetic and reconstructive surgery indications where Galatea Surgical's GalaFLEX Scaffold competes.
  • Allergan Aesthetics (AbbVie): Allergan Aesthetics supplies products into the plastic and reconstructive surgery channel that Galatea targets, including tissue-support and breast-reconstruction adjuncts, and represents a competing commercial footprint in aesthetic surgery.
  • Becton Dickinson (BD): BD appears to be the commercial partner branding GalaFLEX. As a global medical device conglomerate with its own surgical mesh, suture, and biosurgery lines, BD is both a likely owner/partner and a direct competitive incumbent in soft-tissue reinforcement.

Direct peers

  • Integra LifeSciences: Integra LifeSciences develops regenerative tissue technologies and surgical scaffolds used in reconstructive, neurosurgical, and plastic surgery — a directly comparable product category to Galatea's soft-tissue reinforcement scaffolds.

Market position

Customer concentration

Galatea Surgical social profiles

Digital presence

Galatea Surgical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Galatea Surgical leadership team

Management profile

Number of profiles

Profiles1 record

Galatea Surgical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Galatea Surgical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Galatea Surgical

What does Galatea Surgical do?

Galatea Surgical is a medical device company that develops and markets the GalaFLEX Scaffold, a surgical scaffold device designed for soft tissue repair and reinforcement during aesthetic plastic and reconstructive surgery procedures. The company sells its products to surgical and medical professionals requiring tissue support scaffolds.

When was Galatea Surgical founded?

Galatea Surgical was founded in 2011. It employs 11 to 50 people.

Where is Galatea Surgical based?

Galatea Surgical is headquartered in Lexington, United States, in the North America region.

Who are Galatea Surgical's main competitors?

Broad incumbents on record are Coloplast, Medtronic, Ethicon (Johnson & Johnson), Allergan Aesthetics (AbbVie) and Becton Dickinson (BD). Integra LifeSciences is listed as a direct peer.

Does Galatea Surgical have an API?

No public API is recorded for Galatea Surgical.

What industry is Galatea Surgical in?

Galatea Surgical's product category is Plastic and Reconstructive Surgery Medical Devices. Its primary akta.pro industry code is HLAHADAL, Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireGalatea Surgical, Subsidiary of Tepha Inc., Announces Publication of GalaFLEX™ Post-Market Study ResultsGalatea Surgical, a wholly owned subsidiary of Tepha Inc., announced the publication of a clinical study in the Aesthetic Surgery Journal investigating the performance of its GalaFLEX™ Surgical Scaffold in elective mastopexy procedures. The prospective study followed 62 patients treated by six plastic surgeons over one year and concluded that the bioresorbable scaffold safely and effectively supports elevated breast tissue with maintained support at one year. Tepha's CEO commented on the company's commitment to scientific evidence and the product's sustained support capabilities for aesthetic surgeons and their patients.PR NewswireGalatea Surgical Soft Tissue Support Scaffold Products to be Featured At the 2017 American Society of Plastic Surgeons MeetingGalatea Surgical, a wholly owned subsidiary of Tepha Inc., will be a featured exhibitor at the 2017 American Society of Plastic Surgeons Meeting in Orlando, Florida from October 6-10. The company will present clinical experience with its GalaSHAPE 3D and GalaFORM 3D Bioresorbable Surgical Scaffolds, the first scaffold constructs for aesthetic surgery featuring three-dimensional contouring design, through Dr. Bruce Van Natta's presentation on October 6th. The products are made from P4HB polymer technology developed by Tepha and are indicated for support, reinforcement, and elevation of weakened soft tissue in plastic and reconstructive surgery.PR NewswireTepha Inc. Subsidiary, Galatea Surgical, Announces the Launch of GalaFORM™ 3D Surgical ScaffoldGalatea Surgical, a wholly owned subsidiary of Tepha Inc., announced FDA 510(k) clearance for its GalaFORM™ 3D Surgical Scaffold for use in plastic and reconstructive surgery. The product, based on Tepha's proprietary P4HB™ bioresorbable polymer technology, is the only 3-dimensionally contoured surgical scaffold with a reinforcing rim designed to uplift the body's natural shape, provide easier placement, and reduce procedure time. Galatea will commercially launch the product at the 50th Anniversary meeting of the American Society for Aesthetic Plastic Surgery in San Diego, California.PR NewswireTepha Inc. Subsidiary, Galatea Surgical, Announces Launch of GalaSHAPE™ 3D Surgical ScaffoldGalatea Surgical, a wholly owned subsidiary of Tepha Inc., announced the full launch of its GalaSHAPE 3D Surgical Scaffold, a bioresorbable mesh device for aesthetic plastic surgery based on Tepha's proprietary P4HB polymer technology, following FDA 510(k) clearance obtained in fall 2016. The product is the only three-dimensional bioresorbable mesh device indicated for support, reinforcement, and elevation of weakened soft tissue in plastic and reconstructive surgery. Tepha and its partners have received twenty-three 510(k) clearances for U.S. devices and CE Marking for five products sold in Europe, with P4HB-based products used in over one million surgical procedures worldwide.PR NewswireTepha Inc. Subsidiary, Galatea Surgical, Announces Presentation of GalaFLEX™ Surgical Scaffold Clinical Data at London Breast MeetingGalatea Surgical, a wholly owned subsidiary of Tepha Inc., presented clinical data supporting its GalaFLEX Surgical Scaffold for mastopexy procedures at the London Breast Meeting on November 16, 2016. The company also announced that the first GalaFLEX aesthetic breast procedure performed outside the United States was completed in London by plastic surgeon Patrick Mallucci. The GalaFLEX Scaffold is made from Tepha's proprietary resorbable polymer P4HB, which has received CE Mark approval for European marketing and has been used in over one million surgical procedures worldwide.